Report quantifies misdiagnosis of dangerous diseases in the United States
Jul 25, 2023
Total serious harms were extrapolated to affect 795,000 in the US, with 15 dangerous diseases accounting for half of the serious harms.
Severe SARS-CoV-2 appears to infect coronary vessels
Oct 05, 2023
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages.
Risk for diabetes after COVID-19 still increased during omicron phase
Feb 14, 2023
The risk for new-onset diabetes is significantly elevated during the omicron-dominant phase, but no increase was seen for risks for hypertension or hyperlipidemia.
FDA approves Wezlana for multiple inflammatory diseases
Nov 02, 2023
Approval of the biosimilar allows for interchangeable use with Stelara in both adult and pediatric patients
Oral switch noninferior for low-risk S. Aureus bloodstream infection
Jan 26, 2024
Early oral antimicrobial therapy was noninferior to intravenous standard therapy for low-risk bloodstream infection.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
More eye drops recalled due to infection danger
Nov 02, 2023
The new recall affects certain LEADER brand eye drops; the FDA says it found unsanitary conditions in a facility where they are manufactured.
FDA warns eye drops from major brands may cause infection
Oct 30, 2023
Twenty-six products can cause eye infection and blindness, an advisory warns.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Federal final rule drops bring cries of ‘flawed,’ ‘aggressive,’ ‘dramatic’ from senior living...
By
Kimberly Bonvissuto
Apr 25, 2024
Late April brought a shower of regulatory changes as the federal government dropped four major final rules this week that the senior living and care industry is calling “flawed,” “aggressive” and...